Effectiveness of methylprednisolone in acute spinal cord injury - A systematic review of randomized controlled trials

Revista da Associacao Medica Brasileira

Volumn 55, Issue 6, 2009, Pages 729-737

  Botelho, Ricardo Vieira ^a,b   Daniel, Jefferson Walter ^a,c   Boulosa, José Luis Romeo ^a,d   Colli, Benedicto Oscar ^a,d   Farias, Ronald de Lucena ^a,e   Moraes, Osmar José Santos ^a,f   Pimenta Jr , Wilson Eloy ^a,g   Ribeiro, Carlos Henrique ^a,h   Ribeiro, Francisco Ricardo Borges ^a,i   Taricco, Mario Augusto ^a,d   De Carvalho, Marcio Vinhal ^a,j   Bernardo, Wanderley Marques ^a,d  

^a Brazilian Medical Association   (Brazil)

^b INSTITUTO DE ASSISTÊNCIA MÉDICA AO SERVIDOR PÚBLICO ESTADUAL   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^f HOSPITAL SANTA MARCELINA   (Brazil)

^g FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^h FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ Sociedade Brasileira de Neurocirurgia SBN   (Brazil)

^j HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

more..

Author keywords

Methylprednisolone; Methylprednisolone hemisuccinate; Spinal cord injuries

Indexed keywords

METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT; PLACEBO;

HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY;

HUMANS; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL CORD INJURIES;

EID: 77649097728     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302009000600019     Document Type: Article

References (70)

1. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251(1):45-52.
2. Bracken MB, Shepard MJ, Hellenbrand KG, Collins WF, Leo LS, Freeman DF, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg. 1985;63(5):704-13.
3. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405-11.
4. Bracken MB. Pharmacological treatment of acute spinal cord injury: current status and future prospects. Paraplegia. 1992;30(2):102-7.
5. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg. 2000;93(1 Suppl):1-7.
6. Kronvall E, Sayer FT, Nilsson OG. Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned. Lakartidningen. 2005;102(1):24-5.
7. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ. 2003;168(9):1145-6.
8. Citerio G, Cormio M, Sganzerla EP. Steroids in acute spinal cord injury. An unproven standard of care. Minerva Anestesiol. 2002;68(5):315-20.
9. Short D, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: a systematic review from a clinical perspective. Spinal Cord. 2000;38(5):273-86.
10. Short D. Is the role of steroids in acute spinal cord injury now resolved? Curr Opin Neurol. 2001;14(6):759-63.
11. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS II and NASCIS 3 trials. J Trauma. 1998;45(6):1088-93.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
13. Nesathurai S. The role of methylprednisolone in acute spinal cord injuries. J Trauma. 2001;51(2):421-3.
14. Coleman WP, Benzel D, Cahill DW, Ducker T, Geisler F, Green B, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord. 2000;13(3):185-99.
15. Miller SM. Methylprednisolone in acute spinal cord injury: a tarnished standard. J Neurosurg Anesthesiol. 2008;20(2):140-2.
16. Rozet I. Methylprednisolone in acute spinal cord injury: is there any other ethical choice? J Neurosurg Anesthesiol. 2008;20(2):137-9.
17. Zeidman SM, Ling GS, Ducker TB, Ellenbogen RG. Clinical applications of pharmacologic therapies for spinal cord injury. J Spinal Disord. 1996;9(5):367-80.
18. Ducker TB. Treatment of spinal-cord injury. N Engl J Med. 1990;322(20):1459-61.
19. Ducker TB, Zeidman SM. Spinal cord injury. Role of steroid therapy. Spine. 1994;19(20):2281-7.
20. Young W, Bracken MB. The Second National Acute Spinal Cord Injury Study. J Neurotrauma. 1992;9(Suppl 1):S397-405.
21. Young W. Secondary injury mechanisms in acute spinal cord injury. J Emerg Med. 1993;11(Suppl 1):13-22.
22. Bracken MB, Aldrich EF, Herr DL, Hitchon PW, Holford TR, Marshall LF, et al. Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury. J Trauma. 2000;48(3):558-61.
23. Bracken MB. Methylprednisolone and spinal cord injury. J Neurosurg. 2000;93(1 Suppl):175-9.
24. Savitsky E. Role of glucocorticosteroids in treatment of acute spinal cord injury. West J Med. 1996;164(1):69-70.
25. Rosner MJ. Treatment of spinal cord injury. J Neurosurg. 1994;80(5):954-5.
26. Bracken MB. Pharmacological treatment of acute spinal cord injury: current status and future projects. J Emerg Med. 1993;11(Suppl 1):43-8.
27. Hanigan WC, Anderson RJ. Commentary on NASCIS-2. J Spinal Disord. 1992;5(1):125-31.
28. Rosner MJ. National acute spinal cord injury study of methylprednisolone or naloxone. Neurosurgery. 1991;28(4):628-9.
29. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med. 1990;323(17):1207-9.
30. Bracken MB. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. J Neurotrauma. 1991;8(Suppl 1):S47-50.
31. Borgens RB, Toombs JP, Breur G, Widmer WR, Waters D, Harbath AM, et al. An imposed oscillating electrical field improves the recovery of function in neurologically complete paraplegic dogs. J Neurotrauma. 1999;16(7):639-57.
32. Perez-Espejo MA, Haghighi SS, Adelstein EH, Madsen R. The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study. Surg Neurol. 1996;46(4):350-7.
33. Geisler FH, Dorsey FC, Coleman WP. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann Emerg Med. 1993;22(6):1041-7.
34. Geisler FH. GM-1 ganglioside and motor recovery following human spinal cord injury. J Emerg Med. 1993;11(Suppl 1):49-55.
35. Geisler FH. Clinical trials of pharmacotherapy for spinal cord injury. Ann N Y Acad Sci. 1998;19(845):374-81.
36. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and longtract neurological function in NASCIS II. J Neurosurg. 1993;79(4):500-7.
37. Duh MS, Shepard MJ, Wilberger JE, Bracken MB. The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment. Neurosurgery. 1994; 35(2): 240-8;
38. Shepard MJ, Bracken MB. The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS II. National Acute Spinal Cord Injury Study. Paraplegia. 1994;32(4):236-45.
39. Duh M-S, Shepard MJ, Wilberger JE, Bracken MB, Tator CH, Marshall LF. The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment. Neurosurgery. 1994;35(2):240-9.
40. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of highdose methylprednisolone sodium succinate treatment in the followup of acute cervical spinal cord injury. Spine. 2001;26(4):426-30.
41. Pointillart V, Petitjean ME, Wiart L, Vital JM, Lassié P, Thicoipé M, et al. Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord. 2000;38(2):71-6.
42. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg. 1998;89(5):699-706.
43. Petitjean ME, Pointillart V, Dixmerias F, Wiart L, Sztark F, Lassié P, et al. Medical treatment of spinal cord injury in the acute stage. Ann Fr Anesth Reanim. 1998;17(2):114-22.
44. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-604.
45. Epstein N, Hood DC, Ransohoff J. Gastrointestinal bleeding in patients with spinal cord trauma. Effects ofsteroids, cimetidine, and minidose heparin. J Neurosurg. 1981;54(1):16-20.
46. Postigo TR. Metilprednisolona en el tratamiento del trauma2006 raquimedular: analisis de la evidencia. Methylprednisolone in the treatment of the spinal cord injury: analysis of the evidence. Rev Med Clin Condes. 2006;17(1):12-9.
47. Barros Filho TEP. Tratamento medicamentoso no traumatismo raquimedular/Pharmacological management of spinal cord injury. Rev Bras Ortop. 2000;35(5):143-6.
48. Gianchino LM. Consideraciones anestesicas en el paciente con traumatismo raquimedular. Rev Argent Anestesiol.1998;56 (4): 274-80.
49. Gerbrin AS, Cristante AF, Marcon RM, Da-Silva CF. Intervenções farmacológicas no trauma raquimedular: uma nova visão terapêutica. Pharmacological interventions in spinal cord trauma: a therapeutic approach. Acta Ortop Bras.1997;5(3):123-36.
50. San Roman E, Peralta H, Gruenberg M. Trauma de raquis/Spine trauma. Med Intens. 1994;11(2):23-6.
51. Zambrano D. Recientes adelantos en la evaluacion y tratamiento del traumatismo craneoencefalico-espinal severo. Prensa Med Argent. 1982;69(14):575-81.
52. Tebet MA, Barros Filho, TEP, Machado IR, Carvalho, MOP, Hanania FR, Daci K. Efeito da metilprednisolona na lesão medular em ratos: análise functional e histological. Effect of methylprednisolone in medullar injury in rats: a functional and histological analysis. Acta Ortop Bras. 2003;11(2):80-7.
53. Pérez Berrios J, Jiménez Garcia R. Analises de 76 casos de trauma espinal agudo en el Hospital San Juan de Dios.1995-1997. Acta Méd Costarica. 1999;41(2):32-8.
54. Evora PRB, Alegre EMP, Freitas JNA, Nakao RMS, Conceição MC. Edema pulmonary unilateral após trauma medular com comprometimento contralateral do sistema nervoso sintomático J Pneumol.1985;11(4):206-10.
55. Cengiz SL, Kalkan E, Bayir A, Ilik K, Basefer A. Timing of thoracolomber spine stabilization in trauma patients; impact on neurological outcome and clinical course. A real prospective (rct) randomized controlled study. Arch Orthop Trauma Surg. 2008;128(9):959-66.
56. Koyanagi I, Murakami T, Houkin K. Management of acute cervical spine and spinal cord injury using clinical guidelines. Jap J Neurosurg. 2007;16(1):18-25.
57. Martiñon S, Ibarra A. Pharmacological neuroprotective therapy for acute spinal cord injury: State of the art. Minireviews. Med Chem. 2008;8(3):222-30.
58. Adibhatla RM, Hatcher JF. Role of lipids in brain injury and diseases. Future Lidology. 2007;2(4):403-22.
59. Ewart MC, Marshall RW. Perioperative management of the unstable cervical spine. Care Critically Ill. 2006;22(4):82-90.
60. Klussmann S, Martin-Villalba A. Molecular targets in spinal cord injury. J Mol Med. 2005;83(9):657-71.
61. Bossche LV, Vanderstraten G. Heterotopic ossification: a review. J Rehabil Med. 2005;37(3):129-36.
62. Bernhard M, Gries A, Kremer P, Martin-Villalba A, Bottiger BW. Prehospital management of spinal cord injuries. Anaesthesist. 2005;54(4):357-76.
63. Eck JC, Hodges SD, Humphreys SC. Whiplash: a review of a commonly misunderstood injury. Am J Med. 2001;110(8):651-6.
64. Gruen JP, Weiss M. Management of complicated neurologic injuries. Surg Clin North Am. 1996;76(4):905-22.
65. Faden AI. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol. 1996;78(1):12-7.
66. Cronstein BN. Clinical use of methylprednisolone sodium succinate: a review. Curr Ther Res Clin Exp. 1995;56(1):1-15.
67. Cortez R, Levi AD. Acute spinal cord injury. Curr Treat Options Neurol. 2007;9(2):115-12.
68. Ramer LM, Ramer MS, Steeves JD. Setting the stage for functional repair of spinal cord injuries: A cast of thousands. Spinal Cord. 2005;43(3):134-61.
69. Pettersson K, Toolanen G. High-dose methylprednisolone prevents extensive sick leave after whiplash injury. Spine. 1998;23(9):984-9.
70. Trembly B. Clinical potential for the use of neuroprotective agents. A brief overview. Ann Academy Sci. 1995;765(1):1-20.